KR20220016042A - 프로바이오틱 생물막 조성물 및 이의 제조 방법 - Google Patents

프로바이오틱 생물막 조성물 및 이의 제조 방법 Download PDF

Info

Publication number
KR20220016042A
KR20220016042A KR1020217034591A KR20217034591A KR20220016042A KR 20220016042 A KR20220016042 A KR 20220016042A KR 1020217034591 A KR1020217034591 A KR 1020217034591A KR 20217034591 A KR20217034591 A KR 20217034591A KR 20220016042 A KR20220016042 A KR 20220016042A
Authority
KR
South Korea
Prior art keywords
bacteria
biofilm
composition
bacterial
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020217034591A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 다부쉬
도릿 로즈너
스테파니 코헨
힐라 엘리야후
Original Assignee
마이바이오틱스 파마 엘티디.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/368,030 external-priority patent/US10709744B1/en
Application filed by 마이바이오틱스 파마 엘티디. filed Critical 마이바이오틱스 파마 엘티디.
Publication of KR20220016042A publication Critical patent/KR20220016042A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020217034591A 2019-03-28 2020-03-29 프로바이오틱 생물막 조성물 및 이의 제조 방법 Withdrawn KR20220016042A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16/368,030 US10709744B1 (en) 2019-03-28 2019-03-28 Probiotic biofilm suppositories
US16/368,030 2019-03-28
US201962827931P 2019-04-02 2019-04-02
US62/827,931 2019-04-02
PCT/IL2020/050380 WO2020194319A1 (en) 2019-03-28 2020-03-29 Probiotic biofilm compositions and methods of preparing same

Publications (1)

Publication Number Publication Date
KR20220016042A true KR20220016042A (ko) 2022-02-08

Family

ID=72610340

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217034591A Withdrawn KR20220016042A (ko) 2019-03-28 2020-03-29 프로바이오틱 생물막 조성물 및 이의 제조 방법

Country Status (11)

Country Link
EP (1) EP3946392A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022535323A (cg-RX-API-DMAC10.html)
KR (1) KR20220016042A (cg-RX-API-DMAC10.html)
CN (1) CN113766923A (cg-RX-API-DMAC10.html)
AU (1) AU2020250170A1 (cg-RX-API-DMAC10.html)
BR (1) BR112021019437A2 (cg-RX-API-DMAC10.html)
CA (1) CA3131165A1 (cg-RX-API-DMAC10.html)
IL (1) IL286704A (cg-RX-API-DMAC10.html)
MX (1) MX2021011628A (cg-RX-API-DMAC10.html)
SG (1) SG11202110741YA (cg-RX-API-DMAC10.html)
WO (1) WO2020194319A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025532188A (ja) * 2021-09-27 2025-09-29 マイバイオティクス ファーマ リミテッド 微生物組成物、その調製方法およびその使用
CA3247168A1 (en) * 2022-04-05 2023-10-12 Mybiotics Pharma Ltd. BACTERIAL COMPOSITIONS AND METHODS OF CULTURE BACTERIA ON PARTICLES

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2009092810A2 (en) * 2008-01-24 2009-07-30 Bacterfield Oü Single pharmaceutical composition containing antibiotics and probiotics
DE09825657T1 (de) * 2008-11-14 2014-03-13 Unistraw Holdings Pte Ltd. Probiotische Zusammensetzungen, Verfahren und Vorrichtung zu ihrer Verabreichung
IT1400821B1 (it) * 2009-03-09 2013-07-02 Probiotical Spa Sospensione oleosa contenente batteri probiotici per uso pediatrico
ITMI20120131A1 (it) * 2012-02-01 2013-08-02 Probiotical Spa Batteri probiotici microincapsulati multistrato, loro produzione ed uso
EP3536168A3 (en) * 2014-03-06 2019-10-16 The Research Institute at Nationwide Children's Hospital Probiotic formulations and methods for use
CN106232578B (zh) * 2014-03-28 2019-06-07 帝斯曼知识产权资产管理有限公司 从生产类胡萝卜素的生物有机体分离类胡萝卜素的方法
CA2985729C (en) * 2015-05-11 2023-05-09 Mybiotics Pharma Ltd Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
AU2016353091B2 (en) * 2015-11-10 2022-07-14 Probiotech Llc Probiotic delivery systems
WO2017095968A1 (en) * 2015-11-30 2017-06-08 Imagilin Technology Llc Compositions comprising probiotics and methods of use thereof
KR101784847B1 (ko) * 2016-05-10 2017-10-13 주식회사 하우동천 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도
KR102380134B1 (ko) * 2016-05-25 2022-03-29 마이바이오틱스 파마 엘티디. 미생물총 치료를 위한 조성물 및 방법
US11297868B2 (en) * 2016-05-29 2022-04-12 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Method of generating bacterial compositions
WO2018013583A2 (en) * 2016-07-11 2018-01-18 The Brigham And Women's Hospital, Inc. Medicinal vaginal lactobacillus cocktail
EP3388069B1 (en) * 2017-04-12 2019-05-01 ETH Zurich Consortia of living bacteria useful for treatment of microbiome dysbiosis
WO2019136391A1 (en) * 2018-01-05 2019-07-11 Human Longevity, Inc. Probiotic compositions comprising bacteria from bacteroids and firmicutes phyla

Also Published As

Publication number Publication date
MX2021011628A (es) 2021-12-10
EP3946392A4 (en) 2022-12-07
CA3131165A1 (en) 2020-10-01
WO2020194319A1 (en) 2020-10-01
CN113766923A (zh) 2021-12-07
EP3946392A1 (en) 2022-02-09
JP2022535323A (ja) 2022-08-08
BR112021019437A2 (pt) 2021-11-30
IL286704A (en) 2021-10-31
AU2020250170A1 (en) 2021-10-28
SG11202110741YA (en) 2021-10-28

Similar Documents

Publication Publication Date Title
Nath et al. In vitro screening of probiotic properties of Lactobacillus plantarum isolated from fermented milk product
US12036252B2 (en) Pairing probiotics and prebiotics, methods for growth and use, separately and in combination
EP0768375B1 (fr) Bactérie lactique
TWI627276B (zh) 新穎之卷曲乳酸桿菌（ｌａｃｔｏｂａｃｉｌｌｕｓ ｃｒｉｓｐａｔｕｓ）菌株
JP6998892B2 (ja) 細菌組成物の作製方法
CN111088178A (zh) 一种产乳酸和h2o2的乳杆菌及其应用
Nivoliez et al. Influence of manufacturing processes on in vitro properties of the probiotic strain Lactobacillus rhamnosus Lcr35®
Mazhar et al. In vitro safety and functional characterization of the novel Bacillus coagulans strain CGI314
VidyaLaxme et al. Synergistic effects of probiotic Leuconostoc mesenteroides and Bacillus subtilis in malted ragi (Eleucine corocana) food for antagonistic activity against V. cholerae and other beneficial properties
KR20230031333A (ko) 위장 장애가 있는 반려 동물을 지원하기 위한 조성물 및 관련 방법
WO2022151669A1 (en) Lactobacillus amylovorus lam1345 isolate, composition including the same and use thereof
Suomalainen et al. In vitro and in vivo gastrointestinal survival, antibiotic susceptibility and genetic identification of Propionibacterium freudenreichii ssp. shermanii JS
US20150196608A1 (en) Lactobacillus reuteri gmnl-263 composition for controlling body weight and its use thereof
AU2020250170A1 (en) Probiotic biofilm compositions and methods of preparing same
US20200338137A1 (en) Probiotic biofilm suppositories
US10709744B1 (en) Probiotic biofilm suppositories
US20220154134A1 (en) Probiotic biofilm compositions and methods of preparing same
Mikhanoshina et al. New aspects in the study of lactobacillus iners
CN116636616A (zh) 一种稳定的益生菌营养膏及其制备方法和用途
TW201210603A (en) Composition and use of probiotic strain GM-080 in treating cardiac inflammation and apoptosis
WO2022148700A1 (en) Strains, compositions and methods of use
Kumaresan et al. Human breast milk-derived Limosilactobacillus fermentum strains modulate hBD-2 expression against Neisseria meningitidis infection through the TLR-2/p38-MAPK/NF-κB pathway
US20250270536A1 (en) Bacterial compositions and methods for growing bacteria on particles
Ying et al. In Vitro antibacterial activity of Lactiplantibacillus sp. cell-free supernatants against Porphyromonas gingivalis: A potential approach for oral health
KR20250000036A (ko) 비타민 b9을 생성하는 신규한 한국인 유래 균주 락토코커스 락티스 pl186와 이를 유효성분으로 포함하는 건강기능식품 조성물

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203